Advertisement
Research Article

Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial

  • Lynn T. Matthews mail,

    ltmatthews@partners.org

    Affiliations: Massachusetts General Hospital, Division of Infectious Disease, Center for Global Health, Boston, Massachusetts, United States of America, Beth Israel Deaconess Medical Center, Division of Infectious Disease, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Sengeziwe Sibeko,

    Affiliation: Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa

    X
  • Leila E. Mansoor,

    Affiliation: Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa

    X
  • Nonhlanhla Yende-Zuma,

    Affiliation: Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa

    X
  • David R. Bangsberg,

    Affiliations: Massachusetts General Hospital, Division of Infectious Disease, Center for Global Health, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Mbarara University of Science and Technology, Mbarara, Uganda

    X
  • Quarraisha Abdool Karim

    Affiliations: Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa, Mailman School of Public Health, Columbia University, New York, New York, United States of America

    X
  • Published: March 05, 2013
  • DOI: 10.1371/journal.pone.0056400

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.